# #EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes

> **Open Intelligence Dossier** · First detected: 2026-09-30 21:40 UTC · Category: Business

## Executive Summary
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes&quot; is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Endpoints News. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Endpoints News | #EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes | [Source Link](https://news.google.com/rss/articles/CBMiwwFBVV95cUxNSFB0dlM2UDRfMzBjamdldzJScHlCZTRfcTdlaWd4ckRMTzR2Mm1oeWpCRUxyTFNwRVlsLXVRNVJkRmtzWU9qUXF4MG1HT01aekFqOE1pcS1IOTVQQUt4dU5YQ3BZTTcyQmR0cU40RnY1LUg5T2UwVXRZekhneHhZS1drbGNzckRIVVRQWlBTaXJYTTctRHJNM0tuSVdQNTNwZmh6b0RtQjM2dHBXV2Rxam9HcVFtQUkybEoyY19RdDRKdzQ?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-09-30/easd26-lilly-s-amylin-zepbound-combo-posts-best-ever-weight-loss-in-patients*
